- Filed
- Feb 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 6, 2026 | 4.56M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 3.56M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 2.05M sh |
| Shares Diluted restated | Q3 2026 · Dec 31, 2024 | 1.05M sh |
| Shares Diluted restated | Q3 2026 · Dec 31, 2024 | 1.05M sh |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$1.26M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | $548.44K |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $3.51M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $701.3K |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $397.26K |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$2.86M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $1.94M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $5.22M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $1.95M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $5.22M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $4.33M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $2.24M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $5.74M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $5.8M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$0.29 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$0.90 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$0.54 |
| Eps Diluted restated | Q3 2026 · Dec 31, 2024 | −$1.85 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$0.29 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$0.90 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$0.54 |
| Eps Basic restated | Q3 2026 · Dec 31, 2024 | −$1.85 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $651.16K |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $1.7M |
| Sga Expense restated | Q3 2026 · Dec 31, 2024 | $412.27K |
| Sga Expense restated | Q3 2026 · Dec 31, 2024 | $1.42M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$1.04M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$1.85M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$565.32K |
| Net Income | Q3 2026 · Dec 31, 2024 | −$1.95M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$1.1M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$2.16M |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | −$411.04K |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | −$1.16M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $49.48K |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $224.64K |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $105.93K |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $455.91K |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $309.2K |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $994.99K |
| Cost Of Revenue restated | Q3 2026 · Dec 31, 2024 | $345.52K |
| Cost Of Revenue restated | Q3 2026 · Dec 31, 2024 | $1.02M |
| Capex restated | Q3 2026 · Dec 31, 2024 | $418 |